Skip to main content
Journal of Patient-Reported Outcomes
Fig. 2 | Journal of Patient-Reported Outcomes

Fig. 2

From: A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice

Fig. 2

Adherence of 36 ovarian cancer RCTs to CONSORT-PRO items. Legend: *Dark grey shading indicates the abstract identified the PRO as a primary or secondary endpoint, light grey shading indicates the PRO was mentioned in the abstract but endpoint status was unclear. ^Awarded if PRO domains were stated in PRO aims, objectives or hypotheses. CONSORT-PRO items P2b, P6, 13a, 17a and P20/21 contain multiple recommendations and were divided into sub-items for scoring (See Additional file 1: Appendix 1b)

Back to article page